Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sumedha V. Chablani"'
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 66, Iss 3, Pp 393-406 (2022)
ABSTRACT The incidence of differentiated thyroid carcinoma (DTC) has increased in recent decades with early stage, low risk papillary thyroid cancer (PTC) being detected and diagnosed. As a result, the psychological, financial, and clinical ramificat
Externí odkaz:
https://doaj.org/article/1def05c159744ad481b76d6a627b2f03
Autor:
Sumedha V Chablani, Mona M. Sabra
Publikováno v:
Journal of the Endocrine Society
The COVID-19 pandemic has forced endocrinologists to utilize telemedicine to care for their patients. There is limited information on the experience of endocrinologists in managing patients with thyroid cancer virtually. We sent a 9-item questionnair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f9995a32a3beb2a143110684f8e2f9
https://pubmed.ncbi.nlm.nih.gov/34036210
https://pubmed.ncbi.nlm.nih.gov/34036210
Publikováno v:
Journal of the Endocrine Society
Background: The 8th edition of the American Joint Committee on Cancer/tumor-node-metastasis (AJCC/TNM) staging system for differentiated thyroid cancer (DTC), implemented in January 2018, classifies patients >/= 55 years of age with gross extrathyroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f640d8de57cab31b9252e4d0bd9049
http://europepmc.org/articles/PMC8265884
http://europepmc.org/articles/PMC8265884
Publikováno v:
Digestive Diseases and Sciences. 63:2482-2484
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b269eaed5ad5fe1972f1434651b80d6
https://doi.org/10.1007/s10620-018-5194-1
https://doi.org/10.1007/s10620-018-5194-1
Autor:
Sumedha V. Chablani, Nina K. Sundaram, Eliza B. Geer, Alessia Carluccio, Jessica K. Lambert, Levana G. Amrock, Kalmon D. Post
Publikováno v:
Clinical Endocrinology. 82:404-411
Objective To identify predictors for quality of life (QoL) in treated Cushing's disease (CD) and quantify patients' assessment of their disease status. Context Significant reductions in QoL exist in CD patients despite treatment. Identifying predicto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a688e0da92f877578b41e83ad40519e
https://doi.org/10.1111/cen.12521
https://doi.org/10.1111/cen.12521
Autor:
Katherine N. DuHamel, Drusilla White, Steven H. Itzkowitz, Sumedha V. Chablani, Noah Cohen, Lina Jandorf
Publikováno v:
Journal of immigrant and minority health. 19(5)
Colorectal cancer (CRC) screening rates in the U.S. have historically been lower among blacks and Latinos than whites. The advent of a new stool-based test, Cologuard, calls for research to determine which CRC screening test minority individuals migh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5865bcf457147f06ffb78300f5b3c4e7
https://pubmed.ncbi.nlm.nih.gov/27351895
https://pubmed.ncbi.nlm.nih.gov/27351895
Autor:
Katherine N. DuHamel, Pathu Sriphanlop, Cristina Villagra, Lina Jandorf, Steven H. Itzkowitz, Kristen K. Lee, Sumedha V. Chablani
Publikováno v:
Digestive diseases and sciences. 62(6)
Colorectal cancer (CRC) is the second leading malignancy diagnosed among US Latinos. Latinos in the USA represent a heterogeneous amalgam of subgroups varying in genetic background, culture, and socioeconomic status. Little is known about the frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8149bbe6e5eb8304e053af5f126aeba6
https://pubmed.ncbi.nlm.nih.gov/28283848
https://pubmed.ncbi.nlm.nih.gov/28283848
Publikováno v:
American Journal of Gastroenterology. 113:S379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4f83f2f554b0a684a01b5b7cc65d3f0
https://doi.org/10.14309/00000434-201810001-00670
https://doi.org/10.14309/00000434-201810001-00670
Autor:
Lina Jandorf, Linda Thelemaque, Kristen K. Lee, Cristina Villagra, Steven H. Itzkowitz, Sumedha V. Chablani
Publikováno v:
Gastroenterology. 148:S-593
Background: Latinos in the U.S. represent a heterogeneous amalgam of subgroups varying in genetic background, culture, and socioeconomic status. Colorectal cancer is the second leading cancer diagnosed among U.S. Latinos. Little is known about the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a7fa9227ea4aaaff36fa9080fbf338
https://doi.org/10.1016/s0016-5085(15)32007-2
https://doi.org/10.1016/s0016-5085(15)32007-2